PHARMACEUTICAL PREPARATION MANUFACTURING
NAICS 325412
Total Obligations
$59.81B
Total Awards
51K
States
0
Last Updated
Apr 1, 2026
Top 50 Awards in PHARMACEUTICAL PREPARATION MANUFACTURING
Largest individual obligations in NAICS 325412.
| Award | Recipient | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|---|
CONT_IDV_75D30125D00195_7523 VACCINES FOR CHILDREN FY25 | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $2,461,522,172 |
CONT_IDV_75D30123D16108_7523 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $2,437,840,442 |
CONT_IDV_75D30124D18656_7523 2024-2025 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $2,342,411,113 |
CONT_IDV_75D30122D13472_7523 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $2,167,201,004 |
CONT_IDV_75D30121D10575_7523 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $1,887,935,043 |
CONT_IDV_75D30125D00196_7523 VACCINES FOR CHILDREN FY25 | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $1,428,549,577 |
CONT_AWD_36C24026K1002_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2026 | $1,406,868,182 |
CONT_IDV_75D30124D18658_7523 2024-2025 VACCINES FOR CHILDREN | SANOFI VACCINES US INC. Pennsylvania | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $1,277,794,494 |
CONT_IDV_75D30121D10579_7523 VACCINES FOR CHILDREN | PFIZER INC New York | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $1,211,607,191 |
CONT_IDV_75D30120D07516_7523 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $1,203,870,828 |
CONT_AWD_36C24026K1001_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2026 | $1,184,200,532 |
CONT_AWD_36C24025K1012_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 SEPTEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,177,854,443 |
CONT_IDV_75D30122D13473_7523 VACCINES FOR CHILDREN | PFIZER INC New York | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $1,136,023,848 |
CONT_AWD_36C24025K1010_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JULY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,118,034,560 |
CONT_AWD_36C24026K1003_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2026 | $1,110,402,104 |
CONT_AWD_36C24026K1004_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2026 | $1,087,989,766 |
CONT_AWD_36C24025K1011_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 AUGUST | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,075,377,430 |
CONT_AWD_36C24025K1001_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 OCTOBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,047,972,072 |
CONT_AWD_36C24025K1007_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 APRIL | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,045,889,952 |
CONT_AWD_36C24025K1008_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MAY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,043,484,625 |
CONT_AWD_75D30122C14691_7523_-NONE-_-NONE- VACCINE DISTRIBUTION | MCKESSON SPECIALTY DISTRIBUTION LLC Tennessee | Department of Health and Human Services Centers for Disease Control and Prevention | — | MEMPHIS, TN-09 | 2024 | $1,029,830,184 |
CONT_AWD_HHSO100201700019C_7505_-NONE-_-NONE- BAVARIAN NORDIC MOD 19 | BAVARIAN NORDIC A/S | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $1,023,713,981 |
CONT_AWD_36C24025K1009_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JUNE | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $1,020,312,793 |
CONT_AWD_36C24025K1006_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MARCH | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $999,993,461 |
CONT_IDV_75D30124D18657_7523 2024-2025 VACCINES FOR CHILDREN | PFIZER INC New York | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $990,091,120 |
CONT_AWD_36C24024K1010_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JULY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $971,836,194 |
CONT_AWD_36C24024K1012_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 SEPTEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $953,242,300 |
CONT_AWD_36C24024K1011_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 AUGUST | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $943,800,292 |
CONT_IDV_75D30125D00194_7523 END OF PWS | PFIZER INC New York | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $920,931,033 |
CONT_AWD_36C24025K1002_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 NOVEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $911,976,278 |
CONT_AWD_36C24024K1006_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 MARCH | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $851,413,499 |
CONT_AWD_36C24024K1009_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JUNE | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $838,785,945 |
CONT_IDV_75D30120D07513_7523 VACCINES FOR CHILDREN | PFIZER INC New York | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $797,495,916 |
CONT_IDV_75D30125D00198_7523 VACCINES FOR CHILDREN FY25 | GLAXOSMITHKLINE, LLC North Carolina | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2025 | $793,017,790 |
CONT_IDV_75D30124D18655_7523 2024-2025 VACCINES FOR CHILDREN | GLAXOSMITHKLINE, LLC North Carolina | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $771,185,425 |
CONT_AWD_36C24025K1004_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JANUARY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $715,986,475 |
CONT_IDV_75D30123D16109_7523 VACCINES FOR CHILDREN | PFIZER INC New York | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2024 | $706,670,327 |
CONT_AWD_75A50120C00092_7505_-NONE-_-NONE- THE PURPOSE OF THIS ACTION IS TO FUND THE REMAINING APIS FOR THE STRATEGIC RESERVE | PHLOW CORP. Virginia | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | RICHMOND, VA-04 | 2024 | $696,665,954 |
CONT_AWD_36C24025K1003_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 DECEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $659,105,031 |
CONT_AWD_36C24025K1005_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 FEBRUARY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2025 | $633,609,362 |
CONT_AWD_36C24024K1008_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 MAY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $620,873,014 |
CONT_AWD_36C24024K1007_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 APRIL | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $610,147,795 |
CONT_AWD_36C24024K1004_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JANUARY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $608,690,886 |
CONT_AWD_36C24024K1005_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 FEBRUARY | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $567,909,092 |
CONT_AWD_36C24024K1001_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 OCTOBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $559,366,956 |
CONT_AWD_36C24024K1002_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 NOVEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $545,407,050 |
CONT_AWD_36C24024K1003_3600_36W79720D0001_3600 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 DECEMBER | MCKESSON CORPORATION Texas | Department of Veterans Affairs Department of Veterans Affairs | — | IRVING, TX-33 | 2024 | $536,861,081 |
CONT_AWD_SPE2DS22F0022_9700_SPE2DE21D0050_9700 8508632124!QUICKVUE AT-HOME OTC COVID-19 | QUIDEL CORP California | Department of Defense Defense Logistics Agency | — | SAN DIEGO, CA-51 | 2024 | $521,374,748 |
CONT_AWD_75A50119C00037_7505_-NONE-_-NONE- VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATES SERVICES FOR UP TO 10 YEARS. | EMERGENT BIOSOLUTIONS CANADA INC | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $422,315,784 |
CONT_IDV_75D30126D20729_7523 VACCINES FOR CHILDREN | MERCK SHARP & DOHME LLC New Jersey | Department of Health and Human Services Centers for Disease Control and Prevention | — | — | 2026 | $361,340,130 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Source: USAspending.gov · All Industries